Marchioni M., Kriegmair M., Heck M., Amiel T., Porpiglia F., Checcucci E., et al. (2021). Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263. EUROPEAN UROLOGY ONCOLOGY, 4(3), 517-517 [10.1016/j.euo.2021.04.007].

Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263

Pavan N.;
2021-01-01

2021
Marchioni M., Kriegmair M., Heck M., Amiel T., Porpiglia F., Checcucci E., et al. (2021). Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263. EUROPEAN UROLOGY ONCOLOGY, 4(3), 517-517 [10.1016/j.euo.2021.04.007].
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S258893112100081X-main.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 156.74 kB
Formato Adobe PDF
156.74 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/662395
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact